Loading
Pharma Equity Group A/S Stock: price and insider trades · Denmark
Pharma Equity Group A/S: what insiders have been doing
Insider filings for Pharma Equity Group A/S are scarce in the Finanstilsynet DK feed, the latest one published on 14 October 2024. This page will fill in as new trades are disclosed. This summary is built from Finanstilsynet DK disclosures alone and does not predict where the share price will go.
Insider Decl.
2
Thresholds
n/a
Buy Volume
€7,170
1 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
DKK 0.09
Analyst consensus
Income statement
EBITDA-DKK 23.6M
Net income-DKK 25.4M0.0% margin
Valuation
P/Book4.0x
Beta1.00
Balance sheet & cash
Market capDKK 104.3M
Total debtDKK 8.1M
Free Cash Flow-DKK 17.7M
Debt / Equity32%
Profitability & ownership
ROE-87.3%
ROA-35.8%
% insiders0.0%
% institutions0.6%
Last declaration on 14 October 2024
About Pharma Equity Group A/S
Pharma Equity Group A/S is a company focused on the healthcare and pharmaceutical sector. It is listed on the XCSE exchange.
